liverlymph
nodespecif
intercellular
adhes
integrin
lsign
facilit
hepat
c
viru
hcv
infect
interact
hcv
envelop
protein
signal
event
trigger
via
lsign
poorli
understood
kinas
cascad
rafmekerk
pathway
defin
upon
treatment
cell
stabl
express
lsign
bound
cell
interact
lsign
bind
subsequ
result
phosphoryl
activ
raf
mek
erk
blockag
lsign
antibodi
lsign
reduc
phosphoryl
raf
mek
erk
cell
infect
cell
culturederiv
hcv
phosphoryl
kinas
enhanc
upregul
rafmekerk
pathway
hcv
via
lsign
provid
new
insight
signal
cascad
lsign
might
potenti
target
control
prevent
hcv
infect
dendrit
cellspecif
intercellular
adhes
nonintegrin
dcsign
type
ii
integr
membran
protein
extracellular
ctermin
region
contain
calciumdepend
carbohydr
recognit
domain
homologu
dcsign
livelymph
nodespecif
intercellular
adhes
integrin
lsign
also
term
dcsignrel
exhibit
amino
acid
sequenc
ident
dcsign
show
similar
extracellular
region
well
interact
human
immunodefici
viru
hiv
lsign
abundantli
express
endotheli
cell
liver
lymph
node
dcsign
lsign
demonstr
recognit
captur
receptor
bacteria
virus
yeast
parasit
lsign
play
import
role
pathogenesi
varieti
virus
hiv
ebola
viru
hepat
c
viru
hcv
hepat
b
viru
dengu
viru
sindbi
viru
filovirus
sever
acut
respiratori
syndrom
coronaviru
influenza
viru
semliki
forest
viru
particular
lsign
enhanc
viral
entri
target
cell
facilit
infect
interact
viral
envelop
glycoproteinscontain
carbohydr
structur
engag
cellular
receptor
requir
convey
extracellular
signal
intracellular
pathway
compris
kinas
cascad
modul
signal
pathway
dcsign
involv
induct
immun
respons
numer
pathogen
howev
littl
known
signal
cascad
lsign
upon
ligand
bind
hcv
envelop
glycoprotein
believ
initi
hcv
attach
via
cellular
receptor
lsign
captur
deliv
hcv
particl
liver
interact
bind
hcv
target
cell
via
relev
receptor
requir
cell
entri
also
receptorsmedi
signal
hypothesi
interact
lsign
hcv
might
trigger
signal
cascad
respons
hcv
pathogenesi
aberr
regul
mitogenactiv
protein
kinas
mapk
pathway
occur
viru
infect
rafmekerk
key
mapk
pathway
identifi
novel
targetbas
approach
cancer
treatment
previous
report
mapk
signal
trigger
hcv
protein
interact
lowdens
lipoprotein
receptor
human
hepatoma
lymphoma
cell
aim
investig
role
lsign
transmit
hcv
rafmekerk
pathway
cell
stabl
express
lsign
cascad
rafmekerk
signal
defin
upon
hcv
treatment
pathway
also
studi
cell
infect
cell
culturederiv
hcv
hcvcc
result
indic
lsign
mediat
earli
signal
event
trigger
hcv
protein
solubl
hcv
subtyp
protein
express
chines
hamster
ovari
cell
puriti
mous
mab
gift
michael
houghton
chiron
corpor
emeryvil
ca
usa
goat
antihcv
antibodi
purchas
biodesign
intern
saco
main
usa
mous
antihuman
dcsign
mab
clone
antihuman
lsign
mab
clone
purchas
bd
pharmingen
san
diego
ca
usa
r
system
minneapoli
mn
usa
respect
rabbit
antibodi
craf
mek
erk
phosphomek
phosphoerk
bactin
purchas
cell
signal
technolog
beverli
usa
fluorescein
isothiocyan
fitc
conjug
goat
antimous
igg
rabbit
antigoat
igg
jackson
immunoresearch
west
grove
pa
usa
horseradish
peroxidaseconjug
goat
antirabbit
igg
alkalin
phosphataseconjug
goat
antirabbit
antimous
igg
vector
lab
burlingam
ca
usa
bovin
serum
albumin
bsa
phosphat
nitro
blue
tetrazolium
obtain
sigma
st
loui
mo
usa
chemiluminesc
detect
reagent
millipor
billerica
usa
cell
stabli
express
lsign
design
obtain
nih
aid
research
refer
reagent
program
divis
aid
niaid
nih
usa
gener
stabl
transduct
mlv
vector
mxlsign
encod
human
lsign
grown
dulbeccosmodifi
eagl
medium
dmem
contain
fetal
bovin
serum
hyclon
usa
experi
cell
maintain
h
serumfre
dmem
addit
stimuli
hcvcc
hcv
genotyp
produc
transfect
kind
gift
charl
rice
center
studi
hepat
c
rockefel
univers
ny
usa
cell
laboratori
viru
gener
collect
cultur
medium
cell
infect
hcvcc
stock
viru
titer
determin
describ
lsign
express
assess
appropri
amount
cell
suspend
bsa
incub
h
mous
antilsign
mab
final
concentr
lgml
cell
incub
isotypematch
mous
igg
control
two
wash
phosphatebuff
salin
pb
cell
stain
fitcconjug
goat
antimous
igg
min
wash
pb
fix
paraformaldehyd
subject
flow
cytometri
use
fac
calibur
bd
san
jose
ca
usa
cellquest
softwar
data
acquisit
analysi
bind
hcv
protein
evalu
brief
cell
incub
h
lgml
wash
twice
pb
incub
lgml
mous
mab
anoth
h
two
wash
pb
cell
stain
fitcconjug
goat
antimous
igg
min
wash
pb
analyz
bind
cell
incub
mab
secondari
antibodi
control
inhibit
assay
cell
preincub
h
antilsign
mab
combin
antidcsign
mab
cell
wash
pb
remov
unbound
mab
follow
incub
lgml
h
wash
cell
incub
h
lgml
goat
ab
bind
detect
fitcconjug
rabbit
antigoat
igg
confoc
microscopi
cell
fix
paraformaldehyd
min
wash
pb
block
bsa
min
cell
incub
h
lgml
mous
antilsign
mab
follow
three
wash
pb
cell
stain
min
fitcconjug
goat
antimous
igg
wash
pb
bound
polyllysinetr
glass
coverslip
stain
cell
analyz
use
leica
tc
laser
scan
confoc
microscop
heidelberg
germani
imag
captur
process
tc
softwar
verifi
specif
effect
hcv
lgml
mix
lgml
goat
ab
mous
mab
h
mixtur
allow
treat
cell
cell
serum
starv
h
prior
treatment
min
lgml
mixtur
ab
mab
receptorblock
studi
cell
serumstarv
preincub
h
antilsign
mab
combin
antidcsign
mab
prior
treatment
lgml
anoth
min
cell
wash
pb
cell
lysat
prepar
describ
cell
seed
plate
day
wash
twice
pb
incub
dmem
contain
lgml
hcv
protein
h
wash
pb
hcvcc
stock
focusform
unitsml
ad
plate
llwell
allow
proceed
anoth
h
cell
wash
pb
lyse
kinas
measur
equal
amount
protein
extract
cell
lysat
subject
western
blot
analysi
protein
separ
sdspage
transfer
onto
nitrocellulos
membran
block
nonfat
milk
membran
incub
overnight
rabbit
antibodi
craf
mek
erk
phosphomek
phosphoerk
follow
incub
alkalin
phosphatas
horseradish
peroxidaseconjug
secondari
antibodi
immun
complex
visual
phosphat
nitro
blue
tetrazolium
substrat
chemiluminesc
detect
reagent
experi
imag
captur
genegnom
hr
imag
captur
cambridg
uk
band
intens
quantifi
use
genetool
softwar
syngen
lsign
bind
receptor
hcv
protein
wonder
function
perform
lsign
signal
event
trigger
hcv
chosen
cell
line
investig
rafmekerk
signal
respons
hcv
treatment
express
lsign
first
analyz
flow
cytometri
figur
show
lsign
express
lsign
cell
high
level
lsign
express
parent
cell
cellular
local
lsign
also
character
confoc
microscopi
expect
lsign
inde
local
surfac
fig
lsign
unobserv
hcv
bind
cell
via
lsign
next
examin
whether
solubl
hcv
subtyp
protein
bound
cell
figur
show
capabl
effici
bind
contrast
bind
data
shown
confirm
specif
interact
antibodi
lsign
dcsign
assess
inhibit
bind
cell
preincub
antibodi
prior
incub
bind
detect
flow
cytometri
shown
fig
bind
inhibit
antilsign
mab
concentrationdepend
manner
combin
antidcsign
mab
antilsign
mab
display
greater
inhibitori
effect
bind
examin
whether
rafmekerk
pathway
would
affect
hcv
stimul
kinas
phosphoryl
analyz
western
blot
cell
stimul
treatment
cell
led
increas
phosphoryl
raf
mek
erk
level
kinas
phosphoryl
lower
ab
mab
treatment
fig
indic
specif
phosphoryl
activ
kinas
total
raf
mek
erk
constant
sampl
dehydrogenas
gapdh
level
determin
control
protein
load
sinc
lsignmedi
hcv
bind
fig
wonder
whether
activ
raf
mek
erk
induc
interact
lsign
cell
phosphoryl
kinas
thu
evalu
cell
pretreat
variou
concentr
antilsign
mab
prior
treatment
figur
show
pretreat
antilsign
mab
reduc
phosphoryl
raf
mek
erk
compar
alon
treatment
fig
pretreat
lgml
antidcsign
mab
combin
lgml
antidcsign
mab
lgml
antilsign
mab
significantli
reduc
raf
mek
erk
phosphoryl
cell
consist
inhibit
fig
case
lsigndefici
cell
level
raf
mek
erk
phosphoryl
influenc
addit
differ
kinas
phosphoryl
observ
treatment
pretreat
antidcsign
mab
antilsign
mab
fig
result
indic
hcv
interact
lead
phosphoryl
activ
raf
mek
erk
base
data
obtain
uninfect
cell
investig
rafmekerk
pathway
follow
hcvcc
infect
hcvccinfect
cell
level
raf
mek
erk
phosphoryl
slightli
increas
compar
uninfect
cell
treatment
led
strong
phosphoryl
kinas
fig
wherea
enhanc
unobserv
hcvccinfect
cell
treatment
highli
impli
interact
hcv
lsign
account
kinas
phosphoryl
actin
level
determin
control
protein
load
provid
evid
lsign
mediat
bind
hcv
target
cell
bind
subsequ
result
upregul
rafmekerk
pathway
lsign
bind
captur
receptor
hcv
captur
circul
hcv
particl
facilit
viru
infect
hepatocyt
lymphocyt
subpopul
allow
establish
persist
infect
modul
dendrit
cell
function
previous
address
interact
hcv
protein
lowdens
lipoprotein
receptor
attach
entri
receptor
hcv
natur
express
human
hepatoma
lymphoma
cell
hepatocyt
primari
target
hcv
infect
liverderiv
cell
line
standard
model
hcv
research
experi
transfect
lsign
use
gener
character
function
lsign
murin
cell
line
express
cellular
receptor
hcv
beyond
lsign
thu
allow
evalu
signal
event
mediat
lsign
data
also
demonstr
suitabl
cell
line
investig
rafmekerk
signal
follow
lsignhcv
interact
solubl
hcv
envelop
glycoprotein
regard
surrog
studi
viruscel
interact
put
hcv
receptor
includ
lowdens
lipoprotein
receptor
scaveng
receptor
class
b
type
identifi
use
inde
found
hcv
protein
express
chines
hamster
ovari
cell
capabl
effici
bind
cell
first
lsign
shown
express
high
level
cell
fig
specif
interact
confirm
inhibit
assay
data
show
bind
inhibit
antilsign
mab
well
combin
antibodi
lsign
dcsign
fig
indic
antibodi
may
function
compet
ligand
lsign
exhibit
inhibitori
effect
bind
accordingli
lsign
mediat
bind
target
cell
accord
report
hcv
protein
interact
primari
cell
cell
line
express
lsign
exampl
pseudotyp
lentiviru
particl
present
hcv
glycoprotein
bind
cell
express
lsign
solubl
hcv
protein
bind
hela
cell
stabli
express
lsign
hcv
protein
bind
human
monocytederiv
dendrit
cell
trex
cell
express
lsign
outlin
differ
includ
form
cell
type
occur
previou
report
data
engag
activ
rafmekerk
cascad
result
affect
postentri
event
hcv
life
cycl
interact
respiratori
syncyti
viru
glycoprotein
g
lsign
activ
erk
howev
signal
event
trigger
hcv
lsign
poorli
defin
sinc
lsign
cell
specif
interact
hcv
therebi
investig
consequ
aris
interact
result
show
stimul
phosphoryl
raf
mek
erk
enhanc
cell
fig
receptorblock
experi
carri
confirm
specif
interact
respons
effect
found
antilsign
mab
pretreat
reduc
phosphoryl
raf
mek
erk
induc
fig
consist
inhibitori
effect
antibodi
bind
addit
inhibit
kinas
phosphoryl
antidcsign
mab
may
attribut
capac
antibodi
crossreact
dcsign
lsign
fig
moreov
unspecif
effect
antibodi
lsign
dcsign
kinas
phosphoryl
rule
evidenc
pretreat
antibodi
led
reduc
kinas
phosphoryl
cell
fig
thu
respons
phosphoryl
raf
mek
erk
depend
lsign
express
would
import
address
signal
event
trigger
infecti
hcvcc
bear
protein
hcvcc
infect
also
led
activ
rafmekerk
pathway
cell
treatment
enhanc
kinas
phosphoryl
fig
suggest
engag
lsign
protein
well
hcvcc
account
pathway
activ
support
data
zhang
et
al
report
hcv
infect
activ
rasrafmek
pathway
result
demonstr
interact
lsign
hcv
upregul
rafmekerk
pathway
investig
signal
event
cell
endogen
express
lsign
would
necessari
valid
role
lsign
promot
infect
pathogenesi
hcv
